Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Risk Factors for Aneurysm Rebleeding

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Fujian Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Qingsong Lin, Fujian Medical University
ClinicalTrials.gov Identifier:
NCT01567449
First received: March 25, 2012
Last updated: March 28, 2012
Last verified: March 2012

March 25, 2012
March 28, 2012
September 2011
March 2012   (final data collection date for primary outcome measure)
Aneurysm rebleeding [ Time Frame: up to 7 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01567449 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Risk Factors for Aneurysm Rebleeding
Risk Factors in Predicting Spontaneous Intracranial Aneurysm Rebleeding During Hospitalization

The purpose of this study is to examine the risk factors for aneurysm rebleeding.

To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.

Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

A total of 66 SAH patients were enrolled in this study

Subarachnoid Hemorrhage, Aneurysmal
Not Provided
  • the case group
    The case group referred to SAH patients with aneurysm rebleeding
  • the control group
    the control group referred to SAH patients not with aneurysm rebleeding
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
66
April 2012
March 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included

Exclusion Criteria:

  • Rebleeding patients with certain inducing factors such as:

    • severe emotional episode,
    • severe coughing,
    • constipation,
    • excessive activities, or
    • with coagulation disorder,or
    • with other intracranial vascular malformations,such as:

      • moyamoya disease,
      • arteriovenous malformation were excluded.
  • Also patients who rebled while angiography were excluded.
Both
Not Provided
No
Contact: qingsong lin, master 13489991226 lqs1210305061@163.com
China
 
NCT01567449
110011
Yes
Qingsong Lin, Fujian Medical University
Fujian Medical University
Not Provided
Study Director: Dezhi kang, professor First Affiliated Hospital of Fujian Medical University
Fujian Medical University
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP